Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.
01 1BACHEM AMERICAS, INC.
02 2Bachem AG
03 1Bachem Americas, Inc.
04 1USV Private Limited
05 1Ambiopharm, Inc.
06 1Assia Chemical Industries Ltd - Teva Tech Site
07 1Aurobindo Pharma Limited
08 1BCN PEPTIDES SA
09 1Chemical & Biopharmaceutical Laboratories of Patras S.A.
10 1Chengdu Shengnuo Biopharm Co. Ltd.
11 1FRESENIUS KABI IPSUM SRL
12 1Hainan Shuangcheng Pharmaceuticals Co., Ltd.
13 1LSNE, Inc.
14 1MYLAN LABORATORIES LIMITED
15 1PolyPeptide Laboratories, Pvt. Ltd.
16 1ScinoPharm Taiwan Ltd.
17 1Sinopep-Allsino Biopharmaceutical Co., Ltd.
18 1Sterling Pharma Solutions Limited
19 1Tianish Laboratories Private Limited
01 3OCTREOTIDE ACETATE
02 5Octreotide
03 7Octreotide Acetate
04 1Octreotide Hydrochloride
05 2Octreotide acetate
06 2octreotide acetate
01 2China
02 1Greece
03 3India
04 1Israel
05 1Spain
06 1Sweden
07 5Switzerland
08 1Taiwan
09 4U.S.A
10 1United Kingdom
Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.
NDC Package Code : 52416-109
Start Marketing Date : 2018-04-06
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 62147-0206
Start Marketing Date : 2010-09-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (100g/100g)
Marketing Category : BULK INGREDIENT
Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.
NDC Package Code : 52416-123
Start Marketing Date : 2020-06-26
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.
NDC Package Code : 55463-0035
Start Marketing Date : 2019-10-11
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.
NDC Package Code : 55463-0038
Start Marketing Date : 2023-10-23
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 41524-0007
Start Marketing Date : 2012-09-06
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 35207-0002
Start Marketing Date : 2013-11-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 32861-0005
Start Marketing Date : 2015-08-18
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 52958-117
Start Marketing Date : 2024-05-02
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (500g/500g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 50384-6400
Start Marketing Date : 2023-07-03
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (3kg/3kg)
Marketing Category : BULK INGREDIENT
A Octreotide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Octreotide, including repackagers and relabelers. The FDA regulates Octreotide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Octreotide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Octreotide manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Octreotide supplier is an individual or a company that provides Octreotide active pharmaceutical ingredient (API) or Octreotide finished formulations upon request. The Octreotide suppliers may include Octreotide API manufacturers, exporters, distributors and traders.
click here to find a list of Octreotide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Octreotide as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Octreotide API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Octreotide as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Octreotide and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Octreotide NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Octreotide suppliers with NDC on PharmaCompass.
We have 17 companies offering Octreotide
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?